Literature DB >> 15805995

IL-5 and thromboxane A2 receptor gene polymorphisms are associated with decreased pulmonary function in Korean children with atopic asthma.

Soo-Jong Hong1, So-Yeon Lee, Hyo-Bin Kim, Ja-Hyung Kim, Bong-Seong Kim, Soo-Ok Choi, Seong-Gene Lee, Eun-Soon Shin, Taek-Jong Hong.   

Abstract

BACKGROUND: Asthmatic airways undergo chronic inflammatory cell infiltration by T cells and eosinophils, which results in sustained airway hyperresponsiveness. IL-5 is important for eosinophil-induced airway inflammation and airway hyperresponsiveness. Thromboxane A2 and its receptor, TBXA2R, are involved in constriction of respiratory smooth muscles and may play a role in thickening and remodeling of airways, which contributes to the severity of asthma. The relationship between IL-5 and TBXA2R gene polymorphisms and pulmonary function in children with asthma has rarely been examined.
OBJECTIVE: To determine whether IL-5 (T-746C) and TBXA2R (T924C) gene polymorphisms are associated with asthma phenotype and pulmonary function in Korean children with atopic and nonatopic asthma.
METHODS: We conducted an association study between known polymorphisms of IL-5 (T-746C) and TBXA2R (T924C) and asthma phenotype and the parameters of atopy and pulmonary function in atopic and nonatopic Korean children with asthma. The subjects were 240 atopic children with asthma, 70 nonatopic children with asthma, and 106 nonatopic healthy children. Asthma phenotypes and bronchial responsiveness to methacholine were determined by a physician. IL-5 and TBXA2R gene polymorphisms were determined by genotyping by using PCR-RFLP assays.
RESULTS: The genotype frequencies of IL-5 and TBXA2R polymorphisms did not differ between healthy controls and atopic or nonatopic children with asthma. A significant association was observed between the IL-5 polymorphism and forced expiratory flow at 25% to 75% of forced vital capacity (FEF 25-75% ; %; P = .002), and between the TBXA2R polymorphism and FEV 1 (%; P = .035) and FEF 25-75% (%; P = .042) in children with atopic asthma, whereas no such association between the polymorphisms and lung function was observed in nonatopic or control children. In atopic children with asthma, we identified a significant gene-gene interaction in that the combination of the IL-5 (T-746C) and TBXA2R (T924C) mutant alleles was shown to be associated with reduced pulmonary function as determined by FEF 25-75% (%) measurement.
CONCLUSION: The current study indicates that IL-5 (T-746C) and TBXA2R (T924C) polymorphisms alone are associated with spirometric markers of asthma severity, whereas they are not associated with presence of asthma per se. In addition, the data suggest that an interaction between IL-5 and TBXA2R genes may contribute to the severity of asthma, especially atopic asthma. These results suggest that IL-5 and TBXA2R genes may be disease-modifying genes in Korean children with atopic asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805995     DOI: 10.1016/j.jaci.2004.10.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population.

Authors:  Rajeev Mahajan; Emad M El-Omar; Jolanta Lissowska; Paolo Grillo; Charles S Rabkin; Andrea Baccarelli; Meredith Yeager; Leslie H Sobin; Witold Zatonski; Stephen J Channock; Wong-Ho Chow; Lifang Hou
Journal:  Jpn J Clin Oncol       Date:  2008-08-07       Impact factor: 3.019

2.  Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.

Authors:  Cielito C Reyes-Gibby; Sanjay Shete; Trude Rakvåg; Samrat V Bhat; Frank Skorpen; Eduardo Bruera; Stein Kaasa; Pål Klepstad
Journal:  Pain       Date:  2006-12-06       Impact factor: 6.961

3.  Multilocus analysis of atopy in Korean children using multifactor-dimensionality reduction.

Authors:  Heung-Woo Park; Eun-Soon Shin; Jong-Eun Lee; Hyouk-Soo Kwon; Eunyoung Chun; Sun-Sin Kim; Yoon-Seok Chang; Yoon-Keun Kim; Kyung-Up Min; You-Young Kim; Sang-Heon Cho
Journal:  Thorax       Date:  2006-11-22       Impact factor: 9.139

Review 4.  Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease.

Authors:  Scott Gleim; Zsolt Kasza; Kathleen Martin; John Hwa
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 5.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

6.  Site-directed mutations and the polymorphic variant Ala160Thr in the human thromboxane receptor uncover a structural role for transmembrane helix 4.

Authors:  Raja Chakraborty; Sai Prasad Pydi; Scott Gleim; Shyamala Dakshinamurti; John Hwa; Prashen Chelikani
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

7.  The Association of Lung Function, Bronchial Hyperresponsiveness, and Exhaled Nitric Oxide Differs Between Atopic and Non-atopic Asthma in Children.

Authors:  Eunhee Shim; Eun Lee; Song I Yang; Young Ho Jung; Geun Mi Park; Hyung Young Kim; Ju Hee Seo; Jinho Yu
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-05       Impact factor: 5.764

8.  Polymorphisms of immunity genes and susceptibility to otitis media in children.

Authors:  Johanna Nokso-Koivisto; Tasnee Chonmaitree; Kristofer Jennings; Reuben Matalon; Stan Block; Janak A Patel
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

9.  Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis.

Authors:  Scott Gleim; Jeremiah Stitham; Wai Ho Tang; Hong Li; Karen Douville; Prashen Chelikani; Jeffrey J Rade; Kathleen A Martin; John Hwa
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  IL-5 Promoter Polymorphism Enhances IgE Responses to Staphylococcal Superantigens in Adult Asthmatics.

Authors:  Purevsuren Losol; Seung-Hyun Kim; Eui-Kyung Hwang; Yoo Seob Shin; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2012-09-20       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.